1.Brunt, EM, Wong, VW, Nobili, V, et al. (2015) Nonalcoholic fatty liver disease. Nat Rev Dis Primers 1, 15080.
2.Musso, G, Cassader, M & Gambino, R (2016) Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies. Nat Rev Drug Discov 15, 249–274.
3.Leamy, AK, Egnatchik, RA & Young, JD (2013) Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog Lipid Res 52, 165–174.
5.Richter, K & Kietzmann, T (2016) Reactive oxygen species and fibrosis: further evidence of a significant liaison. Cell Tissue Res 365, 591–605.
6.Tosello-Trampont, AC, Landes, SG, Nguyen, V, et al. (2012) Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production. J Biol Chem 287, 40161–40172.
7.Shi, H, Kokoeva, MV, Inouye, K, et al. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116, 3015–3025.
8.Snodgrass, RG, Huang, S, Choi, IW, et al. (2013) Inflammasome-mediated secretion of IL-1β in human monocytes through TLR2 activation; modulation by dietary fatty acids. J Immunol 191, 4337–4347.
9.Guicciardi, ME, Deussing, J, Miyoshi, H, et al. (2000) Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 106, 1127–1137.
10.Miura, K, Kodama, Y, Inokuchi, S, et al. (2010) Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1β in mice. Gastroenterology 139, 323–334.e327.
11.Yamaguchi, K, Itoh, Y, Yokomizo, C, et al. (2010) Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice. Lab Invest 90, 1169–1178.
12.Talbot, NA, Wheeler-Jones, CP & Cleasby, ME (2014) Palmitoleic acid prevents palmitic acid-induced macrophage activation and consequent p38 MAPK-mediated skeletal muscle insulin resistance. Mol Cell Endocrinol 393, 129–142.
13.Miura, K, Yang, L, van Rooijen, N, et al. (2012) Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am J Physiol Gastrointest Liver Physiol 302, G1310–G1321.
14.Pellicoro, A, Ramachandran, P, Iredale, JP, et al. (2014) Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol 14, 181–194.
15.Amalraj, A, Pius, A, Gopi, S, et al. (2017) Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives – a review. J Tradit Complement Med 7, 205–233.
16.Kim, M, Chun, S & Choi, J (2013) Effects of turmeric (Curcuma longa L.) on antioxidative systems and oxidative damage in rats fed a high fat and cholesterol diet. J Korean Soc Food Sci Nutr 42, 570–576.
17.Sun, DI, Nizamutdinova, IT, Kim, YM, et al. (2008) Bisacurone inhibits adhesion of inflammatory monocytes or cancer cells to endothelial cells through down-regulation of VCAM-1 expression. Int Immunopharmacol 8, 1272–1281.
18.Mehra, KS, Mikuni, I, Gupta, U, et al. (1984) Curcuma longa (Linn) drops in corneal wound healing. Tokai J Exp Clin Med 9, 27–31.
19.Li, Y, Shi, X, Zhang, J, et al. (2014) Hepatic protection and anticancer activity of curcuma: a potential chemopreventive strategy against hepatocellular carcinoma. Int J Oncol 44, 505–513.
20.Kawasaki, K, Muroyama, K, Yamamoto, N, et al. (2015) A hot water extract of Curcuma longa inhibits adhesion molecule protein expression and monocyte adhesion to TNF-α-stimulated human endothelial cells. Biosci Biotechnol Biochem 79, 1654–1659.
21.Uchio, R, Higashi, Y, Kohama, Y, et al. (2017) A hot water extract of turmeric (Curcuma longa) suppresses acute ethanol-induced liver injury in mice by inhibiting hepatic oxidative stress and inflammatory cytokine production. J Nutr Sci 6, e3.
22.Kawasaki, K, Muroyama, K, Kondo, S, et al. (2016) Effect of a combination of hot water extract of Curcuma longa and curcumin on serum liver enzymes and emotional states in healthy participants with moderately high body mass index – a randomized, double-blind, placebo-controlled clinical trial. Jpn Pharmacol Ther 44, 593–602.
23.Kawasaki, K, Muryama, K, Fukuhara, I, et al. (2017) Effect of a combination of hot water extract of Curcuma longa and curcumin on serum liver enzymes, inflammatory markers, and emotional states in healthy participants with moderately high body mass index – a randomized, double-blind, placebo-controlled clinical trial. Jpn Pharmacol Ther 45, 243–252.
24.Matsumoto, M, Hada, N, Sakamaki, Y, et al. (2013) An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int J Exp Pathol 94, 93–103.
25.Chiba, T, Suzuki, S, Sato, Y, et al. (2016) Evaluation of methionine content in a high-fat and choline-deficient diet on body weight gain and the development of non-alcoholic steatohepatitis in mice. PLOS ONE 11, e0164191.
26.Rinella, ME, Elias, MS, Smolak, RR, et al. (2008) Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J Lipid Res 49, 1068–1076.
27.Leclercq, IA, Farrell, GC, Field, J, et al. (2000) CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105, 1067–1075.
28.Marcolin, E, San-Miguel, B, Vallejo, D, et al. (2012) Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis. J Nutr 142, 1821–1828.
29.Karmen, A, Wróblewski, F & LaDue, JS (1955) Transaminase activity in human blood. J Clin Invest 34, 126–133.
30.Fischer, AH, Jacobson, KA, Rose, J, et al. (2008) Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc 2008, pdb.prot4986.
31.Gascon-Barre, M, Huet, PM, Belgiorno, J, et al. (1989) Estimation of collagen content of liver specimens. Variation among animals and among hepatic lobes in cirrhotic rats. J Histochem Cytochem 37, 377–381.
32.Morris, L, Graham, CF & Gordon, S (1991) Macrophages in haemopoietic and other tissues of the developing mouse detected by the monoclonal antibody F4/80. Development 112, 517–526.
33.Xu, H, Barnes, GT, Yang, Q, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821–1830.
34.Hara, A & Radin, NS (1978) Lipid extraction of tissues with a low-toxicity solvent. Anal Biochem 90, 420–426.
35.Ohara, T, Muroyama, K, Yamamoto, Y, et al. (2015) A combination of glucosyl hesperidin and caffeine exhibits an anti-obesity effect by inhibition of hepatic lipogenesis in mice. Phytother Res 29, 310–316.
36.Peskin, AV & Winterbourn, CC (2000) A microtiter plate assay for superoxide dismutase using a water-soluble tetrazolium salt (WST-1). Clin Chim Acta 293, 157–166.
37.Ou, Q, Weng, Y, Wang, S, et al. (2018) Silybin alleviates hepatic steatosis and fibrosis in NASH mice by inhibiting oxidative stress and involvement with the Nf-κB pathway. Dig Dis Sci 63, 3398–3408.
38.Rahman, I, Kode, A & Biswas, SK (2006) Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc 1, 3159–3165.
39.Sahai, A, Malladi, P, Melin-Aldana, H, et al. (2004) Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am J Physiol Gastrointest Liver Physiol 287, G264–G273.
40.Lee, GS, Yan, JS, Ng, RK, et al. (2007) Polyunsaturated fat in the methionine–choline-deficient diet influences hepatic inflammation but not hepatocellular injury. J Lipid Res 48, 1885–1896.
41.Ohkawa, H, Ohishi, N & Yagi, K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95, 351–358.
42.Pfaffl, MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45.
43.Livak, KJ & Schmittgen, TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25, 402–408.
44.Day, CP & James, OF (1998) Steatohepatitis: a tale of two “hits”? Gastroenterology 114, 842–845.
45.Stankovic, MN, Mladenovic, D, Ninkovic, M, et al. (2014) The effects of α-lipoic acid on liver oxidative stress and free fatty acid composition in methionine–choline deficient diet-induced NAFLD. J Med Food 17, 254–261.
46.Marra, F & Lotersztajn, S (2013) Pathophysiology of NASH: perspectives for a targeted treatment. Curr Pharm Des 19, 5250–5269.
47.Hassan, W, Rongyin, G, Daoud, A, et al. (2014) Reduced oxidative stress contributes to the lipid lowering effects of isoquercitrin in free fatty acids induced hepatocytes. Oxid Med Cell Longev 2014, 313602.
48.Egnatchik, RA, Leamy, AK, Noguchi, Y, et al. (2014) Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes. Metabolism 63, 283–295.
49.Mari, M, Caballero, F, Colell, A, et al. (2006) Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab 4, 185–198.
50.Wang, L, Liu, J, Zhang, A, et al. (2012) BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice. PLOS ONE 7, e40056.
51.Paik, JS, Cho, WK, Oh, EH, et al. (2012) Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy. Mol Vis 18, 1467–1477.
52.Staiger, H, Staiger, K, Stefan, N, et al. (2004) Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. Diabetes 53, 3209–3216.
53.Ishikado, A, Nishio, Y, Yamane, K, et al. (2009) Soy phosphatidylcholine inhibited TLR4-mediated MCP-1 expression in vascular cells. Atherosclerosis 205, 404–412.
54.Braunersreuther, V, Viviani, GL, Mach, F, et al. (2012) Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J Gastroenterol 18, 727–735.
55.Naito, Y, Shimozawa, M, Manabe, H, et al. (2004) Inhibitory effects of red wine extracts on endothelial-dependent adhesive interactions with monocytes induced by oxysterols. Biol Res 37, 231–238.
56.Nieto, N (2006) Oxidative-stress and IL-6 mediate the fibrogenic effects of [corrected] Kupffer cells on stellate cells. Hepatology 44, 1487–1501.
57.Kagan, P, Sultan, M, Tachlytski, I, et al. (2017) Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation. PLOS ONE 12, e0176173.
58.Xiong, W, Frasch, SC, Thomas, SM, et al. (2013) Induction of TGF-β1 synthesis by macrophages in response to apoptotic cells requires activation of the scavenger receptor CD36. PLOS ONE 8, e72772.
59.Li, HY, Ju, D, Zhang, DW, et al. (2015) Activation of TGF-β1–CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis. Sci Rep 5, 16552.
60.Lee, KS, Buck, M, Houglum, K, et al. (1995) Activation of hepatic stellate cells by TGF α and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 96, 2461–2468.
61.Li, S, Yuan, W, Deng, G, et al. (2011) Chemical composition and product quality control of turmeric (Curcuma longa L.). Pharm Crop 2, 28–54.
62.Leclercq, IA, Farrell, GC, Sempoux, C, et al. (2004) Curcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol 41, 926–934.
63.Kuo, JJ, Chang, HH, Tsai, TH, et al. (2012) Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis. Int J Mol Med 30, 673–679.
64.Aggarwal, BB, Yuan, W, Li, S, et al. (2013) Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: identification of novel components of turmeric. Mol Nutr Food Res 57, 1529–1542.
65.Liu, T, Zhang, L, Joo, D, et al. (2017) NF-κB signaling in inflammation. Signal Transduct Target Ther 2, 17023.
66.Kawasaki, K, Okuda-Hanafusa, C, Aoyagi, M, et al. (2018) Inhibitory effect of the compounds from the water extract of Curcuma longa on the production of PGE2 and NO in a macrophage cell line stimulated by LPS. Biosci Biotechnol Biochem 82, 2109–2117.